Labomatica is a Polish biotechnology company established in 2015 and the main integrator of the AGAMEDE system. The company is supported by a team of 25 talented people with various competences and extensive professional experience. The team includes roboticists, programmers, molecular biologists, chemists, designers, and sale representatives.



Labomatica provides state-of-the-art robotic systems, artificial intelligent software, chemical compounds storage solutions, and laboratory management systems (LIMS) used by pharmaceutical and biotech companies or academic research laboratories. It delivers high-end instruments and accessories that can be used in basic and translational research, clinical diagnostics, and drug discovery, including high-throughput and combinatorial screening. The flagship product of Labomatica is the Gene Game technology for combinatorial screenings and bioprocess optimisations in a closed-loop manner. Thanks to integration with the most popular scheduling software suits and relational databases, Gene Game automates sample preparation, experimental processing, and data exploration based on artificial intelligence.



In 2022 Labomatica became the finalist of the Innovation AveNEW competition organised by the Society for Laboratory Automation and Screening (SLAS) and joined the group of the 20 most visionary biotechnology startups in the world.